Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue

Issues

Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine

Robert Thimme1 / Christoph Neumann-Haefelin2 / Tobias Boettler3 / Hubert E. Blum4

1Department of Medicine II, University Hospital Freiburg, D-79106 Freiburg, Germany

2Department of Medicine II, University Hospital Freiburg, D-79106 Freiburg, Germany

3Department of Medicine II, University Hospital Freiburg, D-79106 Freiburg, Germany

4Department of Medicine II, University Hospital Freiburg, D-79106 Freiburg, Germany

Corresponding author

Citation Information: Biological Chemistry. Volume 389, Issue 5, Pages 457–467, ISSN (Online) 14374315, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2008.061, March 2008

Publication History

Published Online:
2008-03-27

Abstract

Hepatitis C virus (HCV) causes chronic infection in approximately two-thirds of cases, leading to chronic hepatitis, liver cirrhosis, liver disease, liver failure, and hepatocellular carcinoma in a substantial proportion of the 170 million HCV-infected individuals worldwide. It is generally accepted that the cellular immune response plays the most important role in determining the outcome of HCV infection. First, vigorous, multispecific and sustained CD4+ and CD8+ T-cell responses are associated with viral clearance. Second, depletion studies in chimpanzees, the only other host of HCV besides humans, have shown that both CD4+ and CD8+ T-cells are required for virus elimination. Third, the host's human leukocyte antigen alleles, which restrict the repertoire of CD4+ and CD8+ T-cell responses, influence the outcome of infection. Of note, protective immunity has been demonstrated in population-based studies, as well as in experimentally infected chimpanzees. Thus, a detailed understanding of the mechanisms contributing to the failure of the antiviral immune response should allow successful development of prophylactic and therapeutic vaccination strategies.

Keywords: hepatitis; immune response; T-cells; viral escape

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mark H. Kuniholm, Xianhong Xie, Kathryn Anastos, Robert C. Kaplan, Xiaonan Xue, Andrea Kovacs, Marion G. Peters, Eric C. Seaberg, Audrey L. French, Mary A. Young, Michael Augenbraun, Jeffrey A. Martinson, Kristin A. Bush, Alan L. Landay, and Howard D. Strickler
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, Volume 67, Number 3, Page 295
[2]
M H Kuniholm, K Anastos, A Kovacs, X Gao, D Marti, A Sette, R M Greenblatt, M Peters, M H Cohen, H Minkoff, S J Gange, C L Thio, M A Young, X Xue, M Carrington, and H D Strickler
Genes and Immunity, 2013, Volume 14, Number 5, Page 330
[3]
Wuyang Zhu, Juanjuan Fu, Jian Lu, Yao Deng, Huanqin Wang, Yan Wei, Lingling Deng, Wenjie Tan, and Guodong Liang
Archives of Virology, 2013, Volume 158, Number 5, Page 1013
[4]
Sylvie Lagaye, Hong Shen, Géraldine Rousseau, and Stanislas Pol
Future Virology, 2013, Volume 8, Number 5, Page 493
[6]
Peng Peng Ip, Hans W. Nijman, Jan Wilschut, and Toos Daemen
Antiviral Research, 2012, Volume 96, Number 1, Page 36
[8]
Barton F Haynes, Garnett Kelsoe, Stephen C Harrison, and Thomas B Kepler
Nature Biotechnology, 2012, Volume 30, Number 5, Page 423
[9]
Julia Schmidt, Robert Thimme, and Christoph Neumann-Haefelin
Biomarkers in Medicine, 2011, Volume 5, Number 2, Page 155
[10]
V. C. Edwards, A. W. Tarr, R. A. Urbanowicz, and J. K. Ball
Journal of General Virology, 2012, Volume 93, Number 1, Page 1
[11]
Jie Guan, Bo Wen, Yao Deng, Ke Zhang, Hong Chen, Xiaobing Wu, Li Ruan, and Wenjie Tan
Virology Journal, 2011, Volume 8, Number 1, Page 506
[12]
Christian Markus Lange, Kirsten Roomp, Anette Dragan, Jacob Nattermann, Monika Michalk, Ulrich Spengler, Viola Weich, Thomas Lengauer, Stefan Zeuzem, Thomas Berg, and Christoph Sarrazin
Journal of Hepatology, 2010, Volume 53, Number 6, Page 1022
[13]
Joop E. Arends, Mark A.A. Claassen, Charlotte H.S.B. van den Berg, Nening M. Nanlohy, Karel J. van Erpecum, Bert C. Baak, Andy I.M. Hoepelman, Andre Boonstra, and Debbie van Baarle
Antiviral Research, 2010, Volume 87, Number 3, Page 353
[14]
Johannes G. Bode, Erwin D. Brenndörfer, and Dieter Häussinger
Biological Chemistry, 2008, Volume 389, Number 10
[15]
Mirjam B Zeisel and Thomas F Baumert
Future Microbiology, 2009, Volume 4, Number 5, Page 511
[16]
Hans Dieter Nischalke, Martin Vogel, Stefan Mauss, Axel Baumgarten, Thomas Lutz, Marc Danta, Uwe Naumann, Martin Coenen, Tilman Sauerbruch, Jürgen K Rockstroh, Ulrich Spengler, and Jacob Nattermann
AIDS, 2010, Volume 24, Number 13, Page 2001
[17]
Naim Alkhouri, Ibrahim A. Hanouneh, Rocio Lopez, and Nizar N. Zein
Liver Transplantation, 2010, Volume 16, Number 2, Page 155
[18]
R. F. Schinazi, L. Bassit, and C. Gavegnano
Journal of Viral Hepatitis, 2010, Volume 17, Number 2, Page 77
[19]
S.H.E. Kaufmann, A.L. Meinke, and A. von Gabain
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2009, Volume 52, Number 11, Page 1069
[20]
Xinjian Zhang, Jun Dou, and Markus W. Germann
Medicinal Research Reviews, 2009, Volume 29, Number 6, Page 843

Comments (0)

Please log in or register to comment.